Drug Shortage Report for COUMADIN TAB 10MG
Report ID | 51538 |
Drug Identification Number | 01918362 |
Brand name | COUMADIN TAB 10MG |
Common or Proper name | Warfarin |
Company Name | BRISTOL-MYERS SQUIBB CANADA |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | WARFARIN SODIUM |
Strength(s) | 10MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 1 BTL x 100 |
ATC code | B01AA |
ATC description | ANTITHROMBOTIC AGENTS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2018-12-03 |
Actual start date | 2018-12-03 |
Estimated end date | 2018-12-07 |
Actual end date | 2018-12-06 |
Shortage status | Resolved |
Updated date | 2018-12-07 |
Company comments | Stock will be allocated until the new lot arrives. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2344 BOUL. ALFRED-NOBEL, SUITE 300 ST-LAURENT, QUEBEC CANADA H4S 0A4 |
Company contact information | For more information please contact the Customer Service Desk at 1-800-267-0005 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.